![Jesse Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jesse Hall
Hoofd Techniek/Wetenschap/O&O bij
ACLARIS THERAPEUTICS, INC.
Vermogen: 140 634 $ op 31-07-2026
Profiel
Jesse Hall is currently Chief Medical Officer at Aclaris Therapeutics, Inc. since 2025.
Formerly, Mr. Hall was Chief Medical Officer at AltruBio, Inc. Education includes an undergraduate degree from the University of San Diego and a doctorate from the University of Oklahoma College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-05-2026 | 27.045 ( 0,02% ) | 140 634 $ | 31-07-2026 |
Actieve functies van Jesse Hall
| Bedrijven | Functie | Begin |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 29-04-2025 |
Eerdere bekende functies van Jesse Hall
| Bedrijven | Functie | Einde |
|---|---|---|
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jesse Hall
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oklahoma College of Medicine
 University of Oklahoma College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
